Synovium and the innate inflammatory network in osteoarthritis progression topical collection on osteoarthritis

Current Rheumatology Reports

Volumn 15, Issue 5, 2013, Pages

  Liu Bryan, Ru ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cartilage; Crosstalk; DAMPs; Innate immunity; Innate inflammatory network; Osteoarthritis; PRR; Synovium; Toll like receptors

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CD14 ANTIGEN; COMPLEMENT COMPONENT C5; COMPLEMENT COMPONENT C6; COMPLEMENT MEMBRANE ATTACK COMPLEX; CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 1BETA; INTERLEUKIN 6; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ARTICLE; ARTICULAR CARTILAGE; BONE EROSION; CARTILAGE DEGENERATION; CELL STRESS; COMPLEMENT ACTIVATION; CYTOKINE PRODUCTION; DISEASE COURSE; EXTRACELLULAR MATRIX; HUMAN; INNATE IMMUNITY; JOINT DESTRUCTION; KNEE OSTEOARTHRITIS; NONHUMAN; OSTEOARTHRITIS; PATHOGENESIS; RHEUMATOID ARTHRITIS; SYNOVITIS; T LYMPHOCYTE ACTIVATION; TH1 CELL; ANIMAL; APOPTOSIS; IMMUNOLOGY; INFLAMMATION; PATHOLOGY; REVIEW; SIGNAL TRANSDUCTION; SYNOVIUM;

ANIMALS; APOPTOSIS; CARTILAGE, ARTICULAR; DISEASE PROGRESSION; HUMANS; IMMUNITY, INNATE; INFLAMMATION; OSTEOARTHRITIS; RECEPTOR CROSS-TALK; RECEPTORS, PATTERN RECOGNITION; SIGNAL TRANSDUCTION; SYNOVIAL MEMBRANE; SYNOVITIS;

EID: 84877876602     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-013-0323-5     Document Type: Article

References (57)

1. •• Loeser RF, Goldring SR, Scanzello CR, Goldring MB. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum. 2012;64:1697-707. This excellent review summarizes the key features of OA in various tissues affected, and provides an overview of the currently known mechanisms that contribute to the pathological changes in these tissues.
2. Sellam J, Berenbaum F. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev Rheumatol. 2010;6:625-35.
3. Goldring MB, Otero M. Inflammation in osteoarthritis. Curr Opin Rheumatol. 2011;23:471-8.
4. Piccinini AM, Midwood KS. DAMPening inflammation by modulating TLR signalling. Mediators Inflamm. 2010; 2010. pii: 672395.
5. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 2010;11:373-84.
6. •• Scanzello CR, Goldring SR. The role of synovitis in osteoarthritis pathogenesis. Bone. 2012;51:249-57. This review provides insights into the pathogenic mechanisms underlying the development synovitis in OA.
7. Bobacz K, Sunk IG, Hofstaetter JG, Amoyo L, Toma CD, Akira S, et al. Toll-like receptors and chondrocytes: the lipopolysaccharide-induced decrease in cartilage matrix synthesis is dependent on the presence of toll-like receptor 4 and antagonized by bone morphogenetic protein 7. Arthritis Rheum. 2007;56:1880-93. (Pubitemid 47110387)
8. Kim HA, Cho ML, Choi HY, Yoon CS, Jhun JY, Oh HJ, et al. The catabolic pathway mediated by Toll-like receptors in human osteoarthritic chondrocytes. Arthritis Rheum. 2006;54:2152-63. (Pubitemid 44051072)
9. Alexiou P, Chatzopoulou M, Pegklidou K, Demopoulos VJ. RAGE: a multi-ligand receptor unveiling novel insights in health and disease. Curr Med Chem. 2010;17:2232-52.
10. Loeser RF, Yammani RR, Carlson CS, Chen H, Cole A, Im HJ, et al. Articular chondrocytes express the receptor for advanced glycation end products: Potential role in osteoarthritis. Arthritis Rheum. 2005;52:2376-85. (Pubitemid 41117422)
11. Foell D, Wittkowski H, Roth J. Mechanisms of disease: a 'DAMP' view of inflammatory arthritis. Nat Clin Pract Rheumatol. 2007;3:382-90. (Pubitemid 47034539)
12. Sofat N. Analysing the role of endogenous matrix molecules in the development of osteoarthritis. Int J Exp Pathol. 2009;90:463-79.
13. Liu-Bryan R, Terkeltaub R. The growing array of innate inflammatory ignition switches in osteoarthritis. Arthritis Rheum. 2012;64:2055-8.
14. Andersson U, Harris HE. The role of HMGB1 in the pathogenesis of rheumatic disease. Biochim Biophys Acta. 2010;1799:141-8.
15. Yammani RR. S100 proteins in cartilage: role in arthritis. Biochim Biophys Acta. 1822;2012:600-6.
16. Nakashima M, Sakai T, Hiraiwa H, Hamada T, Omachi T, Ono Y, et al. Role of S100A12 in the pathogenesis of osteoarthritis. Biochem Biophys Res Commun. 2012;422:508-14.
17. • Chockalingam PS, Glasson SS, Lohmander LS. Tenascin-C levels in synovial fluid are elevated after injury to the human and canine joint and correlate with markers of inflammation and matrix degradation. Osteoarthritis Cartilage. 2012 pii: S1063-4584(12)01011-4. This study reported that levels of TN-C are highly elevated in human knee joints after injury or OA that correlated with markers of cartilage degradation and inflammation.
18. Sofat N, Robertson SD, Hermansson M, Jones J, Mitchell P, Wait R. Tenascin-C fragments are endogenous inducers of cartilage matrix degradation. Rheumatol Int. 2012;32:2809-17.
19. Patel L, Sun W, Glasson SS, Morris EA, Flannery CR, Chockalingam PS. Tenascin-C induces inflammatory mediators and matrix degradation in osteoarthritic cartilage. BMC Musculoskelet Disord. 2011;12:164.
20. Liu-Bryan R, Terkeltaub R. Chondrocyte innate immune myeloid differentiation factor 88-dependent signaling drives procatabolic effects of the endogenous Toll-like receptor 2/Toll-like receptor 4 ligands low molecular weight hyaluronan and high mobility group box chromosomal protein 1 in mice. Arthritis Rheum. 2010;62:2004-12.
21. DeGroot J, Verzijl N, Wenting-van Wijk MJ, Jacobs KM, Van El B, Van Roermund PM, et al. Accumulation of advanced glycation end products as a molecular mechanism for aging as a risk factor in osteoarthritis. Arthritis Rheum. 2004;50:1207-15. (Pubitemid 38480831)
22. Sohn DH, Sokolove J, Sharpe O, Erhart JC, Chandra PE, Lahey LJ, et al. Plasma proteins present in osteoarthritic synovial fluid can stimulate cytokine production via Toll-like receptor 4. Arthritis Res Ther. 2012;14:R7.
23. Schelbergen RF, Blom AB, van den Bosch MH, Sloetjes A, Abdollahi-Roodsaz S, Schreurs BW, et al. Alarmin S100A8 and S100A9 elicit a catabolic effect in human osteoarthritic chondrocytes that is dependent on Toll-like receptor 4. Arthritis Rheum. 2012;64:1477-87.
24. Zreiqat H, Belluoccio D, Smith MM, Wilson R, Rowley LA, Jones K, et al. S100A8 and S100A9 in experimental osteoarthritis. Arthritis Res Ther. 2010;12(1):R16.
25. Midwood K, Sacre S, Piccinini AM, Inglis J, Trebaul A, Chan E, et al. Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat Med. 2009;15:774-80.
26. van Beijnum JR, Buurman WA, Griffioen AW. Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1). Angiogenesis. 2008;11:91-9.
27. Rojas A, Delgado-Lopez F, Gonzalez I, Perez-Castro R, Romero J, Rojas I. The receptor for advanced glycation end-products: A complex signaling scenario for a promiscuous receptor. Cell Signal. 2012;25:609-14.
28. • Okamura N, Hasegawa M, Nakoshi Y, Iino T, Sudo A, Imanaka-Yoshida K, et al. Deficiency of tenascin-C delays articular cartilage repair in mice. Osteoarthritis Cartilage. 2010;18:839-48. This paper reports worsened cartilage degeneration and delayed cartilage repair in tenascin-C knockout mice in the aging-related spontaneous OA and mechanical injury-induced OA mouse models.
29. •• Blom AB, van Lent PL, Abdollahi-Roodsaz S, van der Kraan P, van den Berg W. Elusive role for toll like receptor 2 in joint pathology during experimental osteoarthritis. Osteoarthritis and Cartilage. 2011;19 Suppl 1:25. This study shows that TLR2 deficiency increased the extent of OA in the collagenase-induced model of mouse knee OA (which is associated with significant synovitis), but did not decrease experimental OA in the DMM model.
30. •• van Lent PL, Blom AB, Schelbergen RF, Sloetjes A, Lafeber FP, Lems WF, et al. Active involvement of alarmins S100A8 and S100A9 in the regulation of synovial activation and joint destruction during mouse and human osteoarthritis. Arthritis Rheum. 2012;64(5):1466-76. This study reports that S100A8 and S100A9 play a significant role in synovial activation and joint destruction in the collagenase-induced OA model.
31. Cecil DL, Appleton CT, Polewski MD, Mort JS, Schmidt AM, Bendele A, et al. The pattern recognition receptor CD36 is a chondrocyte hypertrophy marker associated with suppression of catabolic responses and promotion of repair responses to inflammatory stimuli. J Immunol. 2009;182:5024-31.
32. Ruiz-Romero C, Calamia V, Mateos J, Carreira V, Martinez-Gomariz M, Fernandez M, et al. Mitochondrial dysregulation of osteoarthritic human articular chondrocytes analyzed by proteomics: a decrease in mitochondrial superoxide dismutase points to a redox imbalance. Mol Cell Proteomics. 2009;8(1):172-89.
33. Scott JL, Gabrielides C, Davidson RK, Swingler TE, Clark IM, Wallis GA, et al. Superoxide dismutase downregulation in osteoarthritis progression and end-stage disease. Ann Rheum Dis. 2010;69:1502-10.
34. Gavriilidis C, Miwa S, von Zglinicki T, Taylor RW, Young DA. Mitochondrial dysfunction in osteoarthritis is associated with a down-regulation of superoxide dismutase 2. Arthritis Rheum. 2012 Nov 8. doi: 10.1002/art.37782.
35. Finberg RW, Kurt-Jones EA. CD14: chaperone or matchmaker? Immunity. 2006;24:127-9. (Pubitemid 43214581)
36. • Nair A, Kanda V, Bush-Joseph C, Verma N, Chubinskaya S, Mikezcz K, et al. Synovial fluid from patients with early osteoarthritis modulates fibroblast-like synoviocyte responses to TLR4 and TLR2 ligands via soluble CD14. Arthritis Rheum. 2012;64:2268-77. This study reports that soluble CD14 is increased in synovial fluid in both early and advanced stages of human knee OA, and that the synovial fluid of early OA patients can modulate cultured synovial lining cell inflammatory responses to exogenous microbial TLR2 and TLR4 ligands.
37. Carroll MV, Sim RB. Complement in health and disease. Adv Drug Deliv Rev. 2011;63:965-75.
38. Ballanti E, Perricone C, di Muzio G, Kroegler B, Chimenti MS, Graceffa D, et al. Role of the complement system in rheumatoid arthritis and psoriatic arthritis: relationship with anti-TNF inhibitors. Autoimmun Rev. 2011;10:617-23.
39. Konttinen YT, Ceponis A, Meri S, Vuorikoski A, Kortekangas P, Sorsa T, et al. Complement in acute and chronic arthritides: assessment of C3c, C9, and protectin (CD59) in synovial membrane. Ann Rheum Dis. 1996;55:888-94. (Pubitemid 26426682)
40. Gobezie R, Kho A, Krastins B, Sarracino DA, Thornhill TS, Chase M, et al. High abundance synovial fluid proteome: distinct profiles in health and osteoarthritis. Arthritis Res Ther. 2007;9:R36. (Pubitemid 46692394)
41. •• Wang Q, Rozelle AL, Lepus CM, Scanzello CR, Song JJ, Larsen DM, et al. Identification of a central role for complement in osteoarthritis. Nat Med. 2011;17:1674-9. This study highlights a key role of activation of complement cascade, particularly membrane attack complex assembly, in the pathogenesis of OA.
42. Happonen KE, Saxne T, Aspberg A, Morgelin M, Heinegard D, Blom AM. Regulation of complement by cartilage oligomeric matrix protein allows for a novel molecular diagnostic principle in rheumatoid arthritis. Arthritis Rheum. 2010;62:3574-83.
43. Sjoberg A, Onnerfjord P, Morgelin M, Heinegard D, Blom AM. The extracellular matrix and inflammation: fibromodulin activates the classical pathway of complement by directly binding C1q. J Biol Chem. 2005;280:32301-8. (Pubitemid 41361839)
44. Song WC. Crosstalk between complement and toll-like receptors. Toxicol Pathol. 2012;40:174-82.
45. Hajishengallis G, Lambris JD. Crosstalk pathways between Toll-like receptors and the complement system. Trends Immunol. 2010;31:154-63.
46. Zhang X, Kimura Y, Fang C, Zhou L, Sfyroera G, Lambris JD, et al. Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo. Blood. 2007;110:228-36. (Pubitemid 47026839)
47. Lappegard KT, Christiansen D, Pharo A, Thorgersen EB, Hellerud BC, Lindstad J, et al. Human genetic deficiencies reveal the roles of complement in the inflammatory network: lessons from nature. Proc Natl Acad Sci USA. 2009;106:15861-6.
48. Stevens MG, Van Poucke M, Peelman LJ, Rainard P, De Spiegeleer B, Rogiers C, et al. Anaphylatoxin C5a-induced toll-like receptor 4 signaling in bovine neutrophils. J Dairy Sci. 2011;94:152-64.
49. Rittirsch D, Flierl MA, Ward PA. Harmful molecular mechanisms in sepsis. Nat Rev Immunol. 2008;8:776-87.
50. Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP, Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 2011;7:33-42.
51. Su SL, Tsai CD, Lee CH, Salter DM, Lee HS. Expression and regulation of Toll-like receptor 2 by IL-1beta and fibronectin fragments in human articular chondrocytes. Osteoarthritis Cartilage. 2005;13:879-86. (Pubitemid 41430793)
52. Bradley K, North J, Saunders D, Schwaeble W, Jeziorska M, Woolley DE, et al. Synthesis of classical pathway complement components by chondrocytes. Immunology. 1996;88:648-56. (Pubitemid 26255139)
53. Menu P, Vince JE. The NLRP3 inflammasome in health and disease: the good, the bad and the ugly. Clin Exp Immunol. 2011;166:1-15.
54. • Jin C, Frayssinet P, Pelker R, Cwirka D, Hu B, Vignery A, et al. NLRP3 inflammasome plays a critical role in the pathogenesis of hydroxyapatite-associated arthropathy. Proc Natl Acad Sci USA. 2011;108:14867-72. This study shows that the NLRP3 inflammasome mediates synovitis and joint destruction in the pathogenesis of OA associated with deposition of hydroxyapatite.
55. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006;440:237-41. (Pubitemid 43372104)
56. Ishii H, Tanaka H, Katoh K, Nakamura H, Nagashima M, Yoshino S. Characterization of infiltrating T cells and Th1/Th2-type cytokines in the synovium of patients with osteoarthritis. Osteoarthritis Cartilage. 2002A;10:277-81. (Pubitemid 34467631)
57. Abdollahi-Roodsaz S, van de Loo FA, Koenders MI, Helsen MM, Walgreen B, van den Bersselaar LA, et al. Destructive role of myeloid differentiation factor 88 and protective role of TIR-containing adaptor inducing interferon β in IL-17-dependent arthritis. Arthritis Rheum. 2012;64:1838-47.